UTMB Awarded a $15.6 Million/year NIH Grant for Three Years of Vaccine Development With Partners
September 17, 2024
September 17, 2024
GALVESTON, Texas, Sept. 17 -- The University of Texas Medical Branch issued the following news release:
The University of Texas Medical Branch recently received a three-year award of $15.6 million per year from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) to conduct cutting-edge research aimed at developing vaccines and monoclonal antibodies (mAbs) to combat high-priority viral pathogens.
"The ce . . .
The University of Texas Medical Branch recently received a three-year award of $15.6 million per year from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) to conduct cutting-edge research aimed at developing vaccines and monoclonal antibodies (mAbs) to combat high-priority viral pathogens.
"The ce . . .